Distal arthrogryposis type 2b1 is a rare genetic condition that mainly affects the hands and feet. People with distal arthrogryposis type 2b1 have tight joints, curved fingers, and foot deformities such as clubfoot. Facial features can include a small mouth opening, a high-arched palate, and a small lower jaw, and feeding or speech therapy may help. It is lifelong, usually recognized at birth or in early childhood, and intelligence is typically unaffected. Treatment focuses on physical and occupational therapy, splints or casting, and sometimes surgery, and many people live long lives with supportive care.
Overview
Distal arthrogryposis type 2b1Symptoms
Distal arthrogryposis type 2b1 is usually noticed at birth with tight, fixed joints in the hands and feet. Features include overlapping fingers, clenched hands, clubfoot, and limited motion. Some have facial differences, such as a small jaw or high-arched palate.
Outlook and prognosis
Most people with distal arthrogryposis type 2b1 grow and think typically, but joint tightness can limit fine hand use, walking speed, or posture. Early therapy and occasional surgery often improve function. Lifespan is usually typical, with needs changing as joints stiffen over time.
Causes and risk factors
Distal arthrogryposis type 2b1 results from gene changes affecting muscle‑contracting proteins, most often autosomal dominant; many cases are new (de novo). Family history raises risk. Pregnancy factors don’t cause it, though fetal position or growth may influence severity.
Genetic influences
Genetics play a central role in distal arthrogryposis type 2b1; most cases result from inherited variants affecting muscle and joint development. It’s typically autosomal dominant, so one altered copy can cause the condition. Genetic testing helps confirm diagnosis, clarify recurrence risk, and guide family planning.
Diagnosis
Doctors suspect distal arthrogryposis type 2b1 based on characteristic clinical features at birth and family history. The genetic diagnosis of distal arthrogryposis type 2b1 is confirmed with targeted genetic tests; imaging may document limb and joint findings.
Treatment and drugs
Treatment for distal arthrogryposis type 2b1 focuses on easing tight joints, improving movement, and supporting daily activities. Care often includes early, tailored physical and occupational therapy, splints or casting, and targeted orthopedic procedures when needed. Teams may also address feeding, breathing, or pain concerns.
Symptoms
Distal arthrogryposis type 2b1 mainly affects the hands and feet, causing joints to be stiff or fixed in a bent position from birth. Parents often notice early features of Distal arthrogryposis type 2b1 in the newborn period, like tight fingers or clubfeet that can shape how a child grips, crawls, or walks. In daily life, this can affect grip, shoe fit, and activities that rely on fine hand movements. Features vary from person to person and can change over time.
Fingers or thumbs may be fixed in a bent position from birth. Clinicians call this a contracture, which means the joint doesn’t move through its full range. It can make grasping small objects or opening the hand harder.
Wrists can sit in a flexed or tilted position and may not fully straighten. This limits twisting or weight-bearing motions like pushing up from a chair. Bracing and exercises may improve function.
In Distal arthrogryposis type 2b1, clubfoot or other foot shape differences are common. These can affect balance and make walking or shoe fitting harder. Casting, bracing, or surgery are sometimes used to improve alignment.
Elbows or knees may not fully extend. This can make reaching overhead, straightening the arm, or taking longer strides more challenging.
How people usually first notice Distal arthrogryposis type 2b1?
Parents and clinicians often first notice distal arthrogryposis type 2b1 in the newborn period because a baby is born with tight joints in the hands and feet—such as clenched fingers, “hitchhiker” thumbs, or clubfoot—and limited range of motion. Some babies also have facial features that stand out at birth, like a small jaw or distinctive mouth shape, which can prompt early evaluation. These first signs of distal arthrogryposis type 2b1 typically lead to orthopedic and genetics referrals to confirm the diagnosis and start therapies to improve movement.
Types of Distal arthrogryposis type 2b1
Distal arthrogryposis type 2B1 is a genetic/congenital condition with recognized clinical variants that can look a bit different from one another in the hands, feet, facial features, and sometimes the spine. These variants are defined by established subtype names that clinicians use to describe patterns seen at birth and through growth. Not everyone will experience every type. Understanding the main variants can make conversations about the types of distal arthrogryposis type 2B1 clearer for families and care teams.
Sheldon–Hall syndrome
This classic variant features tight joints in the hands and feet at birth, often with finger contractures and clubfoot. Facial features can include a small lower jaw and limited mouth opening. Growth and learning are typically within the expected range.
Freeman–Sheldon–like
This variant shares hand and foot contractures but has more pronounced facial involvement, such as a very small mouth opening and tight facial muscles. Feeding or speech challenges may be more noticeable early on. Breathing issues are uncommon but can occur in some.
Predominantly distal-limb
In this milder variant, contractures mainly affect the hands and feet with little to no facial involvement. Daily function may be less limited, and therapy often focuses on mobility and grasp. People may notice differences most during fine-motor tasks.
With spinal involvement
Some have added spine features like curvature (scoliosis) along with hand and foot contractures. Back stiffness or posture changes may progress with growth. Monitoring by orthopedics can help guide bracing or timing of surgery.
Post-surgical course
This describes those whose main differences emerge in how joints respond after early procedures for clubfoot or finger contractures. Range of motion may improve but can tighten again as growth spurts happen. Regular therapy helps maintain gains and function.
What genetics can tell you about symptoms
Some people with distal arthrogryposis type 2b1 have changes in the TNNI2 or TPM2 genes that affect how muscle fibers contract, leading to tight joints, hand and foot contractures, and limited movement from birth. Certain variants also influence facial features and severity, such as more pronounced clubfoot or deeper hand stiffness.
Causes and risk factors
Distal arthrogryposis type 2b1 is usually caused by a gene change that disrupts how skeletal muscles contract. Many cases involve changes in muscle genes such as TNNI2, TNNT3, or TPM2, and the condition is often inherited in an autosomal dominant way. Some risks are written in our DNA, passed down through families. Risk factors for distal arthrogryposis type 2b1 mainly include having a parent with the gene change, and severity can differ even within a family. A new gene change can also occur for the first time in a child, and lifestyle or environment do not cause it.
Environmental and biological risk factors
Distal arthrogryposis type 2b1 is present from birth and mainly affects the hands and feet, leading to tight joints and curved positions. Doctors often group risks into internal (biological) and external (environmental). This section focuses on environmental and biological risk factors for distal arthrogryposis type 2b1. These factors mainly relate to pregnancy conditions that reduce fetal movement or limit space, which can increase the likelihood or severity of contractures.
When a baby moves less in the womb, joints can stiffen into set positions. This can raise the chance that distal contractures are present at birth in pregnancies affected by distal arthrogryposis type 2b1.
Too little fluid limits room for the baby to move. Reduced movement can increase the likelihood or severity of joint contractures.
A tight or unusually shaped uterus can restrict space. Fibroids or a split-shaped uterus can crowd the fetus and reduce motion, which may make contractures more pronounced.
Twins or triplets share limited space. The crowding can limit limb motion and raise the chance of fixed hand and foot positions.
Genetic risk factors
Distal arthrogryposis type 2b1 is most often linked to single-letter DNA changes in the TNNI2 gene, which helps fast skeletal muscles contract and relax. Most families show autosomal dominant inheritance, meaning one altered copy can be enough to cause the condition. These genetic changes help explain the early symptoms of Distal arthrogryposis type 2b1. Carrying a genetic change doesn’t guarantee the condition will appear.
TNNI2 variants: Changes in the TNNI2 gene can alter how fast skeletal muscles contract and relax. This can limit movement before birth, leading to hand and foot contractures seen at birth. Many different TNNI2 changes have been reported.
Autosomal dominant inheritance: One altered copy is enough to cause Distal arthrogryposis type 2b1. Each child of an affected parent has a 50% (1 in 2) chance to inherit the variant. Severity can differ even within the same family.
De novo variants: Sometimes the variant starts for the first time in a child. In these cases, neither parent carries the change in their blood. The chance of it happening again in future pregnancies is usually low.
Variable expressivity: Features can range from very mild to more noticeable, even among relatives with the same variant. Some may have subtle tightness or mild toe changes, while others have classic hand and foot contractures. This variability can affect when a diagnosis is made.
Reduced penetrance: Some people who carry a TNNI2 variant have few or no clear signs. This can make a family history look negative despite the variant being present.
Parental mosaicism: A parent may carry the variant in a small portion of egg or sperm cells but not in standard blood testing. This can raise the chance of another child with Distal arthrogryposis type 2b1 even when parents test negative.
Family history: Having a parent or close relative with Distal arthrogryposis type 2b1 increases the likelihood of carrying the same variant. Patterns can span several generations.
Lifestyle risk factors
Distal arthrogryposis type 2b1 is a genetic condition; lifestyle habits do not cause it, but they can influence symptoms, function, and complication risk over time. Understanding how lifestyle affects Distal arthrogryposis type 2b1 can help you prioritize daily choices that preserve mobility and comfort. The focus is on routines that maintain range of motion, protect joints, and support recovery if procedures are needed.
Consistent home stretching and splint wear help maintain range in tight hand and foot joints. Skipping sessions can allow contractures to stiffen, making daily tasks and gait harder.
Long periods of sitting or immobility can increase joint stiffness in already contracted wrists, fingers, ankles, and toes. Brief, frequent movement breaks help preserve flexibility and function.
Repeated jumping and running can overload stiff ankles and feet, worsening pain or deformity. Low‑impact options like swimming or cycling build endurance while protecting joint alignment.
Poor wrist and hand ergonomics during work or school can strain shortened tendons and small joints. Neutral positioning, adaptive tools, and therapist‑guided splints reduce pain and overuse.
Risk prevention
Distal arthrogryposis type 2b1 is genetic, so you can’t fully prevent the condition itself, but you can lower the chance of complications and support daily function. Planning ahead—before pregnancy or early in a child’s life—often makes the biggest difference. Prevention works best when combined with regular check-ups. Families can also use genetic counseling to understand inheritance and consider reproductive options.
Learn how the condition is inherited and what it means for future pregnancies. Relatives can consider testing to clarify their own risks.
If a familial variant is known, options like prenatal diagnosis or embryo testing can be discussed. This can guide pregnancy planning and delivery decisions.
Spotting early symptoms of distal arthrogryposis type 2b1 in a newborn allows therapy to start right away. Early action helps prevent tighter joints and secondary problems.
Gentle, frequent range-of-motion exercises keep joints as flexible as possible. A therapist can teach safe techniques and home routines.
Transmission
Distal arthrogryposis type 2b1 is not contagious—you can’t catch it from someone or pass it through casual contact. It’s usually inherited in an autosomal dominant way, meaning if a parent lives with the condition, each child has a 50% chance of inheriting it.
Sometimes Distal arthrogryposis type 2b1 occurs for the first time in a child because of a new genetic change, so parents may not have any symptoms. Even within the same family, features can range from mild to more noticeable. If you’re wondering about the genetic transmission of Distal arthrogryposis type 2b1 or how Distal arthrogryposis type 2b1 is inherited in your family, a genetics provider can review your specific risks.
When to test your genes
Consider genetic testing if you or a close relative were born with hand and foot contractures, facial differences, or suspected distal arthrogryposis, especially before surgery or family planning. Testing can confirm the diagnosis, guide tailored therapies and bracing, and clarify recurrence risk. Prenatal or preconception testing may be helpful when there’s a known family variant.
Diagnosis
Day-to-day, the first clues often appear at birth or soon after, when hands and feet don’t move or straighten as expected. Distal arthrogryposis type 2b1 is usually identified by these distinctive joint contractures and confirmed with specific tests. Getting a diagnosis is often a turning point toward answers and support.
Doctors look for a typical pattern of tight joints in the hands and feet and certain facial features seen at birth. They assess range of motion, muscle tone, and how joints move with gentle stretching. These clinical features guide early diagnosis of distal arthrogryposis type 2b1.
A detailed family and health history can help connect current findings with similar features in relatives. This may point to an inherited pattern. It can also guide which genetic tests are most useful.
The genetic diagnosis of Distal arthrogryposis type 2b1 is usually confirmed using a multi-gene panel. These blood or saliva tests look for changes in genes known to cause distal arthrogryposis. Results can also inform family planning and recurrence risk.
X-rays of hands, feet, and sometimes the jaw help show joint positions and bone alignment. Imaging can document contractures and rule out other skeletal differences. These pictures support the clinical impression.
Stages of Distal arthrogryposis type 2b1
Distal arthrogryposis type 2b1 does not have defined progression stages. Early symptoms of distal arthrogryposis type 2b1 usually show up at birth as limited movement in the hands and feet and certain facial features, and while needs may change with growth, the condition itself typically does not steadily worsen over time. Doctors usually start with a conversation about your pregnancy and birth history and a hands-on exam of joint movement; imaging or movement studies may be used, and genetic testing can help confirm the diagnosis and guide follow-up.
Outlook and prognosis
Looking at the long-term picture can be helpful. For many people with distal arthrogryposis type 2b1, life expectancy is near typical, and the condition tends to be stable after early childhood. Most challenges center on joint stiffness in the hands and feet, limited range of motion, and sometimes facial muscle differences that can affect chewing or speech clarity. Early care can make a real difference, with physical and occupational therapy, bracing, and, when needed, surgery helping children reach key milestones like walking, self-care, and classroom activities.
Prognosis refers to how a condition tends to change or stabilize over time. In distal arthrogryposis type 2b1, joints don’t usually worsen steadily; instead, growth spurts or missed therapy time can make stiffness more noticeable, while regular stretching and guided exercises often maintain function. Some people experience persistent tightness and need occasional procedures, while others notice good mobility with routine therapy and adaptive tools. Serious complications are uncommon, and mortality is not typically increased, though anesthesia planning and airway evaluations are important when facial or jaw differences are present.
The outlook is not the same for everyone, but most children with distal arthrogryposis type 2b1 attend mainstream school, play in ways that suit their range of motion, and become independent adults. Over time, most people find a steady rhythm—therapy check-ins, periodic orthopedics visits, and home programs—to protect flexibility and reduce pain or overuse strain. Genetic testing can sometimes provide more insight into prognosis when a family is planning for future pregnancies or comparing features among relatives. Talk with your doctor about what your personal outlook might look like, including early symptoms of distal arthrogryposis type 2b1 that deserve prompt therapy and what to expect during growth spurts.
Long-term effects
For many living with distal arthrogryposis type 2b1, the long-term picture centers on how joint tightness affects hands, feet, and daily function over time. Long-term effects vary widely, and changes can be subtle or more noticeable during growth or with repetitive use. Most people have stable features with normal intelligence and near-normal life expectancy, though some joints may stay tight into adulthood. This overview reflects the long-term outlook for distal arthrogryposis type 2b1 based on what’s known from clinical follow-up.
Tight fingers and wrist tendons can limit grip, pinch, and fine hand movements. Many grow up learning workarounds, but dexterity may remain reduced.
Clubfoot or high-arched feet can affect balance and walking distance. Some need braces or past surgeries, and alignment changes may persist.
Stiffness in small joints often remains lifelong. Larger joints are usually spared, but tight Achilles or wrist flexors can restrict movement.
Subtle features like a small mouth or triangular face are typically stable. Speech and feeding are usually normal beyond infancy.
How is it to live with Distal arthrogryposis type 2b1?
Living with distal arthrogryposis type 2b1 often means planning around joints that don’t fully bend or straighten, especially in the hands, feet, and sometimes the face, which can make fine motor tasks, walking long distances, or clear facial expressions more effortful. Many find that regular stretching, physical and occupational therapy, and adaptive tools help preserve function and independence, while fatigue management and pacing reduce strain. Family members, classmates, and coworkers may need simple adjustments—extra time for tasks, accessible spaces, and patience with communication or mobility—yet most daily routines, schooling, and work are possible with the right supports. For many, the most helpful ingredient is a care team that adapts treatments over time and a social circle that understands the condition without defining the person by it.
Treatment and drugs
Treatment for distal arthrogryposis type 2b1 focuses on easing joint tightness, improving movement, and supporting daily function rather than “curing” the condition. Early, regular physical and occupational therapy are the backbone of care, using gentle stretching, strengthening, and splints or casts to maintain range of motion; braces and tailored shoes can help with walking, and many benefit from custom hand supports for grasping. Orthopedic surgery may be considered for specific problems such as severe clubfoot, hip or knee contractures, or thumb-in-palm positioning, often followed by structured rehab to protect gains. Doctors sometimes recommend a combination of lifestyle changes and drugs, though medicines mainly target pain, muscle spasms, or postop discomfort rather than the underlying cause. Because needs change with growth and activity, treatment plans often combine several approaches and are reviewed over time by a team that may include genetics, orthopedics, rehab, and pain specialists.
Non-drug treatment
Day-to-day life with Distal arthrogryposis type 2b1 often centers on keeping joints flexible, hands functional, and feet well aligned for sitting, standing, and play. Early treatment for Distal arthrogryposis type 2b1 typically starts in infancy and continues as a tailored rehab plan that grows with your child. Non-drug treatments often lay the foundation for mobility and independence. Teams usually combine therapies, braces, and home routines, adjusting as needs change over time.
Gentle, regular stretching helps keep joints moving and reduce stiffness. Therapists guide safe range-of-motion exercises and teach positioning to protect joints.
Training focuses on hand opening, grasp, and daily skills like dressing or feeding. Therapists may suggest adaptive tools to make tasks easier at home and school.
Custom splints help hold fingers, wrists, or ankles in better positions while tissues lengthen. Short periods of serial casting can gradually improve tight joints.
Structured programs, like the Ponseti method, can help straighten clubfeet over weeks. A brace often follows to maintain alignment as your child grows.
Your genes may have an impact on how drugs work for you
Think of treatment like tuning a joint’s movement: the same dose can act differently depending on your genetic wiring. Variants in drug-processing genes and muscle–nerve pathway genes may change effectiveness, side effects, or dosing needs for distal arthrogryposis type 2b1 therapies.
Pharmacological treatments
Medicines cannot undo joint contractures, but they can make stretching, casting, and recovery more comfortable. Drugs that target symptoms directly are called symptomatic treatments. Medicines don’t change the underlying gene changes or early symptoms of Distal arthrogryposis type 2b1, but they can ease pain and support therapy. Choices depend on age, planned procedures, and how your body tolerates a given drug.
Acetaminophen (paracetamol) and NSAIDs like ibuprofen or naproxen can reduce pain from therapy, casting, or day‑to‑day strain in Distal arthrogryposis type 2b1. Sometimes medicines are taken short-term (acute treatment), while others are used long-term (maintenance therapy). Use the lowest dose that controls pain and watch for stomach or kidney side effects with NSAIDs.
After surgery or intensive casting, short courses of opioids such as oxycodone or morphine may be used for severe pain. These are for brief periods at the smallest effective dose, with a plan to taper off quickly. Prevent constipation with fluids, fiber, and, if needed, a stool softener.
Diazepam or tizanidine may be used short-term for painful muscle tightness, especially at night or after procedures. Dosing may be increased or lowered gradually to balance comfort with sleepiness or dizziness. Baclofen is rarely needed unless there is coexisting spasticity.
Targeted injections can temporarily relax overactive muscles around a stiff joint, sometimes making stretching and casting easier in Distal arthrogryposis type 2b1. Effects typically last about 3–4 months and are given by specialists. Monitoring is important for uncommon side effects like excessive weakness or swallowing troubles.
Genetic influences
In many families, the pattern of tight joints and limited movement present from birth points to an inherited cause. Distal arthrogryposis type 2b1 is most often passed down in an autosomal dominant way—one altered copy of a gene is enough to cause the condition, and each child has a 1 in 2 (50%) chance of inheriting it. Family history is one of the strongest clues to a genetic influence. Still, some people are the first in their family to have it because the gene change arises for the first time in the egg or sperm. The genes involved help skeletal muscles contract before birth; when their function is slightly disrupted, the hands, feet, and facial features can develop differently. Even within the same family, the same gene change can lead to milder or more pronounced findings, so the inheritance pattern of Distal arthrogryposis type 2b1 may look uneven across relatives. Genetic testing can often pinpoint the specific change and help clarify recurrence risks for future pregnancies.
Is Distal arthrogryposis type 2b1 genetic?
Genetics play a central role in distal arthrogryposis type 2b1; most cases result from inherited variants affecting muscle and joint development. It’s typically autosomal dominant, so one altered copy can cause the condition. Genetic testing helps confirm diagnosis, clarify recurrence risk, and guide family planning.
Pharmacogenetics—how genetics influence drug effects
For people with distal arthrogryposis type 2b1, day-to-day care is centered on physical therapy, bracing, and sometimes surgery; medicines are mainly used for pain control and for anesthesia during procedures. The gene changes that cause distal arthrogryposis type 2b1 affect how muscles and tendons develop, but they don’t usually change how the liver breaks down most medicines. That means there isn’t a condition-specific drug or a standard “DA2B1 dosing,” and anesthetic and muscle-relaxant choices are guided by your exam, airway and spine features, and the type of surgery. Genetics is only one factor in medication response; your age, body size, other diagnoses, and current prescriptions also shape what works best. Testing that confirms distal arthrogryposis type 2b1 is different from pharmacogenetic testing, which looks at drug-processing genes; your care team may use each for different decisions. When pain medicines are needed, general pharmacogenetic results—such as how your body handles codeine or tramadol—can help doctors choose safer, more effective options or use different doses. If surgery is planned, tell the anesthesia team about any family history of unusual reactions to anesthesia, and ask about anesthesia considerations for distal arthrogryposis type 2b1 so the plan fits your needs.
Interactions with other conditions
People living with distal arthrogryposis type 2b1 who also have another health issue may find that stiffness and hand or foot contractures are harder to manage, especially during illnesses or after minor injuries. Doctors call it a “comorbidity” when two conditions occur together. In babies, early symptoms of Distal arthrogryposis type 2b1 can overlap with other causes of joint contractures, so teams often check for nerve, brain, or primary muscle disorders that might change treatment plans. When chronic pain, arthritis, or scoliosis are present, they can add to fatigue and limit mobility, which may affect how well braces, casting, or physical therapy work. Distal arthrogryposis type 2b1 by itself does not usually raise the risk of heart, lung, or kidney disease; if those problems show up, clinicians may look for an overlapping diagnosis. Because some of the same muscle proteins are involved across different rare conditions, a relative might have a related muscle problem or milder contractures, and this can guide screening and counseling. If surgery is needed for clubfoot or other orthopedic issues, let your surgical and anesthesia teams know about jaw, neck, or limb limitations so positioning and airway plans can be adjusted safely.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Throughout history, people have described babies born with tightly bent fingers and toes, small jaws, and limited joint movement at birth. Families and midwives noticed patterns—an infant whose hands would not open fully, a relative with similarly curved feet—long before modern names existed. Some communities kept quiet out of worry or stigma; others adapted cradles, swaddles, and early splints to ease daily care.
From early written records to modern studies, the picture gradually sharpened. Doctors first grouped many of these joint-from-birth conditions together under broad labels. Over time, descriptions became more precise as clinicians noticed that some children had mainly hand and foot involvement while others had broader joint stiffness. Reports also highlighted facial features and jaw size in a subset, helping separate one pattern from another. Not every early description was complete, yet together they built the foundation of today’s knowledge.
In recent decades, knowledge has built on a long tradition of observation. Careful family histories showed that the same cluster of features could appear across generations, suggesting a heritable pattern. Researchers then linked certain forms of distal arthrogryposis to changes in genes that guide how muscles contract during development. For the condition now called distal arthrogryposis type 2b1, these discoveries helped explain why hands and feet are often most affected, why the jaw may be small, and why flexibility varies from child to child.
As genetic testing became more available, clinicians could confirm the diagnosis with greater confidence instead of relying only on outward features. This shifted care earlier—prenatal ultrasound sometimes raised the first question when reduced fetal movement or clubfoot was seen, leading to planned supports at birth. With each decade, treatment moved from simple positioning and splints to coordinated, family-centered care: physical and occupational therapy, selective casting or surgery when needed, and dental or speech support if jaw size affected feeding or breathing.
Understandings have changed, but the goals have stayed steady: identify distal arthrogryposis type 2b1 early, support development, and adapt care to the individual. Looking back helps explain why names and categories evolved and why two people in the same family might have different degrees of stiffness or facial features. Today’s approach reflects all those steps—caregivers’ observations, clinicians’ detailed notes, and advances in genetics—coming together to guide clearer diagnosis and more tailored care.